FDA chief says no current plans to restrict mifepristone access

FDA chief says no current plans to restrict mifepristone access

Food and Drug Administration (FDA) Commissioner Marty Makary said he has no plans to change current policy to restrict access to the abortion pill mifepristone, despite a steady pressure campaign from abortion opponents.  Speaking at the Semafor World Economy Summit on Thursday, Makary said he would reconsider if there is new data that would suggest…

FDA Has ‘No Plans’ to Pull Abortion Pill

Food and Drug Administration Commissioner Martin Makary said he has no plans to restrict the availability of the abortion pill mifepristone, which has emerged as a source of debate among conservatives since the Supreme Court overturned Roe v. Wade, Semafor reports.

Report: FDA Commissioner Says ‘No Plans’ to Pull Abortion Drugs

Food and Drug Administration (FDA) Commissioner Martin Makary said on Thursday he has "no plans to take action" to restrict the availability of mifepristone, the first drug used in a two-drug medication abortion regimen. The post Report: FDA Commissioner Says ‘No Plans’ to Pull Abortion Drugs appeared first on Breitbart.

FDA commissioner: ‘No plans’ to restrict mifepristone

WASHINGTON (OSV News) — Food and Drug Administration Commissioner Martin Makary said April 24 he has “no plans” to restrict the availability of mifepristone, a pill commonly used for abortion. In comments at the Semafor World Economy Summit, April 24, Makary said there was no plan to restrict mifepristone, which is the first of two drugs used in a medication or chemical abortion. But Makary did not entirely rule out such restrictions, saying, “t…

What the new FDA commissioner says about possible restrictions on abortion medication

Many conservatives want the FDA to impose tighter restrictions on mifepristone and misoprostol, which can be delivered by mail. The medication accounted for 63 percent of U.S. abortions in 2023. Amna Nawaz spoke with the new FDA commissioner, Dr. Marty Makary, about what the agency may do.

FDA Leader Says He Has No Plan to Act on Abortion Pill Access

Food and Drug Administration Commissioner Marty Makary said he has no plans to change government policy on the abortion pill mifepristone, a hot-button issue in the US since the Supreme Court overturned the landmark Roe v. Wade decision in 2022.